galantamine hydrobromide

This page contains recent news articles, when available, and an overview of galantamine hydrobromide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Dr Reddy's US arm gets nods for Galantamine Hydrobromide Tablets  -  Sep 15, 2008
Drug maker Dr Reddy`s Laboratories has informed that its US subsidiary has received tentative approval from the US Food & Drug Administration (USFDA) for ... Stock watch - Stock Watch

Ortho-McNeil Neurologics to Appeal Patent Ruling on RAZADYNE  -  Aug 28, 2008
The decision allows FDA-approved generic versions of immediate-release galantamine hydrobromide to enter the US marketplace "at risk" pending an appeal. ... FierceBiotech

NICE Revised Alzheimer's Disease Guidance Published  -  Sep 9, 2007
In the UK and Ireland, Shire markets REMINYL® (galantamine hydrobromide) and REMINYL® XL (galantamine hydrobromide) acetylcholinesterase inhibitors that are ... Medical News Today - Medical News Today (press release)

Press Release: Shire Pharmaceuticals Group PLC - Investing in a …  -  Nov 3, 2005
...excluding UK and Republic of Ireland) REMINYL XLA' (galantamine hydrobromide) (trademark of Johnson & Johnson, excluding UK and Republic of Ireland) ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research

Ortho-McNeil to appeal Razadyne patent ruling.  -  Sep 1, 2008
The decision allows FDA-approved generic versions of immediate-release galantamine hydrobromide to enter the US marketplace "at risk" pending an appeal. ... $9.94 - Pharma Marketletter - Alacra Store

Press Release: Barr Confirms Patent Challenge of Razadyne(R) ER …  -  Jul 6, 2006
Therefore ... to Barr's generic Razadyne ER (galantamine hydrobromide ... release capsules. Razadyne ER had annual sales of ... com/. ... Pay-Per-View - PR Newswire - HighBeam Research

Ranbaxy gets tentative FDA approval for making, marketing Galantamine...  -  Aug 30, 2007
India's biggest drug company, said it received tentative FDA approval to manufacture and market Galantamine Hydrobromide tablets in the US. ... Forbes

Press Release: Ortho-McNeil Neurologics to Appeal Patent Ruling on …  -  Aug 28, 2008
The decision allows FDA-approved generic versions of immediate-release galantamine hydrobromide to enter the U.S. marketplace "at risk" pending an appeal. ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Health Authorities Reviewing Safety Data from …  -  Jan 21, 2005
Health Authorities Reviewing Safety Data from Investigational Study Involving REMINYL(R) (galantamine hydrobromide). from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Pharmacotherapy for CFS  -  Oct 4, 2006
13-15 Of note is a large multicenter RCT of the stimulant galantamine hydrobromide that showed no benefit [see sidebar titled “Galantamine Hydrobromide ... ProHealth

Barr Receives Tentative Approval For A Generic Version Of Razadyne …  -  May 12, 2007
Barr filed an Abbreviated New Drug Application (ANDA) with the US Food & Drug Administration (FDA) for Janssen's Razadyne (Galantamine Hydrobromide), 4mg, ... emaxhealth.com

Now available.(Rx)  -  Jul 11, 2005
Galantamine hydrobromide was approved in 2001 as the twice-daily medication Reminyl; the product name was changed in April 2005. For further information ... Free with registration - Drug Topics - AccessMyLibrary.com

Barr Confirms Patent Challenge of Razadyne(R) ER Capsules  -  Jul 6, 2006
Barr filed an ANDA with the FDA for Janssen's Razadyne ER (Galantamine Hydrobromide Extended-Release Capsules), 8 mg, 16 mg and 24 mg in March 2006 . ... Genetic Engineering News - Genetic Engineering News (press release)

Majority of Patients With Mild Alzheimer's Disease Will Remain...  -  Oct 8, 2007
In the UK and Ireland, Shire markets REMINYL(R) (galantamine hydrobromide) and REMINYL XL(R) (galantamine hydrobromide) an acetylcholinesterase inhibitor ... ITNews

Alzheimer's Disease: The Physician's Guide to Practical Management  -  May 22, 2005
Galantamine hydrobromide, the most recent of these drugs, appears to be beneficial with both Alzheimer's disease and cerebrovascular disease. ... RedOrbit

Watson Pharmaceuticals Receives FDA Approval for Generic Razadyne( …  -  Dec 16, 2008
Galantamine hydrobromide extended-release capsules are the generic equivalent to Ortho McNeil Janssen's Razadyne(R) ER, galantamine HBr extended-release ... Genetic Engineering News - Genetic Engineering News (press release)

Barr Confirms Patent Challenge of Razadyne(R) Tablets  -  Jun 20, 2005
Barr filed an Abbreviated New Drug Application (ANDA) with the US Food & Drug Administration (FDA) for Janssen's Razadyne (Galantamine Hydrobromide), 4 mg, ... chemie.de

Press Release: SHIRE PLC - Second quarter 2006 results. - PR …  -  Jul 28, 2006
A' (etodolac) MESAVANCEao (mesalamine) REMINYLA' (galantamine hydrobromide) (UK and Republic of Ireland) REMINYL XLao (galantamine hydrobromide) (UK and ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research

FDA Cautions Against Use of Reminyl for Mild Cognitive Impairment  -  Apr 1, 2005
Editor's note: Ortho-McNeil Neurologics, Inc., announced on April 11, 2005, that its brand name Reminyl (galantamine hydrobromide) would be changed to ... Medscape

Press Release: SHIRE PLC - Strong 2005 performance supports positive ...  -  Feb 23, 2006
A' (etodolac) MESAVANCEao (mesalamine) REMINYLA' (galantamine hydrobromide) (UK and Republic of Ireland) REMINYL XLao (galantamine hydrobromide) (UK and ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research

Press Release: Barr Receives Tentative Approval for a Generic Version...  -  May 11, 2007
Barr filed an Abbreviated New Drug Application (ANDA) with the U.S. Food & Drug Administration (FDA) for Janssen's Razadyne (Galantamine Hydrobromide), 4mg, ... Pay-Per-View - M2 Presswire - HighBeam Research

Press Release: Shire Pharmaceuticals Group PLC - Q2 results with …  -  Jul 28, 2005
...(lanthanum carbonate) REMINYLA[R] (galantamine hydrobromide) (UK and Republic ... of Ferring AS) RAZADYNEacents (galantamine hydrobromide) (trademark of ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research

Press Release: Barr Receives Tentative Approval for a Generic Version...  -  May 11, 2007
Barr filed an Abbreviated New Drug Application (ANDA) with the U.S. Food & Drug Administration (FDA) for Janssen's Razadyne (Galantamine Hydrobromide), 4mg, ... Pay-Per-View - PR Newswire - HighBeam Research

Shire plc: IFRS Information - First Half of 2006.  -  Sep 18, 2006
MESAVANCE(TM) (mesalamine) REMINYL(R) (galantamine hydrobromide)(UK and ... of Ireland) REMINYL XL(TM) (galantamine hydrobromide)(UK and Republic of ... $4.95 - PR Newswire - ECNext

Press Release: Watson Pharmaceuticals Receives FDA Approval for …  -  Dec 16, 2008
Galantamine hydrobromide extended-release capsules are the generic equivalent to Ortho McNeil Janssen's Razadyne(R) ER, galantamine HBr extended-release ... Pay-Per-View - PR Newswire - HighBeam Research

IFRS Information - First Half of 2007.  -  Sep 13, 2007
...(mesalamine) MEZAVANT(R) (mesalazine) REMINYL(R) (galantamine hydrobromide) (UK and Republic of Ireland) REMINYL XL(TM) (galantamine hydrobromide) (UK ... $4.95 - PR Newswire - ECNext

Barr gains approval for generic version of Razadyne: Barr …  -  Nov 10, 2008
...the U.S. Food and Drug Administration for a genetic version of Razadyne ER, Ortho McNeil Janssen's galantamine hydrobromide extended release capsules. ... $9.94 - Drug Topics - Alacra Store

Press Release: Shire Expresses Disappointment at the Publication of...  -  Nov 21, 2006
In the UK and Ireland, Shire markets REMINYL(R) (galantamine hydrobromide) and REMINYL XL(R) (galantamine hydrobromide), an acetylcholinesterase inhibitor ... Pay-Per-View - PR Newswire Europe - HighBeam Research

Press Release: SHIRE PLC - IFRS results for the year ending December ...  -  Mar 23, 2007
...(mesalamine) LODINE A[R] (etodolac) REMINYLA[R] (galantamine hydrobromide) (UK and Republic of Ireland) REMINYL XLacents (galantamine hydrobromide) (UK ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research

Article: USF player Robinson makes an impact as a freshman - Universit...  -  Oct 6, 2005
May 23 /PRNewswire/ -- RAZADYNE(TM) ER (galantamine hydrobromide), a new ... Administration (FDA) in December 2004, RAZADYNE ER contains galantamine ... Pay-Per-View - University Wire - HighBeam Research

Razadyne to get generic rival.  -  Sep 29, 2008
Late last month the court ruled in Barr's favor, clearing the way for it to start making generic Razadyne (galantamine hydrobromide) in 4-mg, ... $9.94 - Chain Drug Review - Alacra Store

Barr Confirms Patent Challenge of Razadyne(R) Tablets.  -  Jun 15, 2005
Barr filed an Abbreviated New Drug Application (ANDA) with the US Food & Drug Administration (FDA) for Janssen's Razadyne (Galantamine Hydrobromide), ... $4.95 - PR Newswire - ECNext

Press Release: Barr Receives Approval for Generic Version of Razadyne(...  -  Aug 28, 2008
Barr filed an Abbreviated New Drug Application (ANDA) with the U.S. Food & Drug Administration (FDA) for Janssen's Razadyne (galantamine hydrobromide), ... Pay-Per-View - PR Newswire - HighBeam Research

Loislaw Federal District Court Opinions - JANSSEN, LP v. BARR …  -  Feb 4, 2008
21-615, which covers controlled release compositions of galantamine hydrobromide as found in RAZADYNE ER(r). (Cmplt. ¶ 17). Plaintiffs also own Patent ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Press Release: Barr Confirms Patent Challenge of Razadyne(R) Tablets....  -  Jun 15, 2005
Barr filed an Abbreviated New Drug Application (ANDA) with the U.S. Food & Drug Administration (FDA) for Janssen's Razadyne (Galantamine Hydrobromide), ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: SHIRE PLC - 1st Quarter Results.(Financial report) -...  -  Apr 25, 2007
GENE-ACTIVATEDA' LIALDAao (mesalamine) REMINYLA' (galantamine hydrobromide) (UK and Republic of Ireland) REMINYL XLao (galantamine hydrobromide) (UK and ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research

Press Release: Barr Receives Approval for Generic Version of Razadyne(...  -  Sep 16, 2008
Therefore, the decision regarding the '318 patent effectively ended the 30-month stay with respect to Barr's generic Razadyne ER (galantamine hydrobromide), ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Award-Winning Documentary on Schizophrenia to Be …  -  May 23, 2005
Article: GALANTAMINE HYDROBROMIDE.(Janssen Pharmaceutica ... Chemical Market Reporter; March 12, 2001 ; 579 words ...Janssen Pharmaceutica Products, L.P., ... Pay-Per-View - PR Newswire - HighBeam Research

Indian shares keep firm Asian picture intact after smooth F&O rollover  -  Aug 31, 2007
The company said yesterday it has won tentative approval from the US Food and Drug Administration for its dementia drug, galantamine hydrobromide tablets, ... Forbes

Ranbaxy gets tentative US nod for dementia drug  -  Dec 27, 2007
BO) has received tentative approval from the US Food and Drug Administration for galantamine hydrobromide oral solution, the regulator's Web site showed. ... Reuters

Health Authorities Reviewing Safety Data From Investigational Study …  -  Jan 21, 2005
...an investigational use of the company's Alzheimer's treatment, REMINYL(R) (galantamine hydrobromide), in individuals with mild cognitive impairment. ... RedOrbit

Nice rejection of Alzheimer's drugs 'a sad day'  -  Nov 22, 2006
The UK-based company produces and manufactures an Alzheimer's drug, Reminyl (galantamine hydrobromide), one of the class of drugs rejected for early stage ... Hays Pharma

J&J Sues Novartis Unit to Block Generic of Razadyne  -  Jun 16, 2008
...said Sandoz's product would infringe a patent for a controlled-release form of galantamine hydrobromide, the active ingredient in Razadyne. ... Bloomberg

Americans still believe myths about Alzheimer's disease .  -  Aug 21, 2006
There are medications availa ble today - such as (galantamine hydrobromide) - which can slow the progression of symptoms, and may allow many patients more ... Southeast Alaska's Island News - Google News Archive

NJ BRIEFS | Article from The Record (Bergen County, NJ) | HighBeam …  -  Jun 16, 2005
...to the U.S. Food and Drug Administration for permission to sell a generic tablet version of galantamine hydrobromide, the key ingredient in Razadyne. ... Pay-Per-View - The Record - HighBeam Research

Eisai, NICE Claim Victory in Alzheimer's Drug Legal Challenge  -  Aug 20, 2007
Shire's Reminyl XR (galantamine hydrobromide) and Novartis' Exelon (rivastigmine tartrate) should be used to treat moderate Alzheimer's disease only, ... FDA news - FDA news (subscription)

加兰他æ•?å?¯æ²»ç–—血管性痴呆  -  Sep 13, 2006
...在今年美国神�学会第53届年会上,芬兰赫尔辛基大学中心医院的一个研究�组报告,溴 氢加兰他�(galantamine hydrobromide, reminyl )对治疗伴有脑血管病或血管性痴呆 ... 新�网河�频�

Galantamine and vascular events.(Safety and Efficacy Issues)  -  Mar 22, 2005
United States of America -- The prescribing information for galantamine hydrobromide (Reminyl[R]) has been updated to reflect the results of two ... Free with registration - WHO Drug Information - AccessMyLibrary.com

加兰他æ•?å?¯æ²»ç–—血管性痴呆  -  Oct 23, 2006
...在美国神�学会第53届年会上,芬兰赫尔辛基大学中心医院的一个研究�组报告,溴氢加 兰他�(galantamine hydrobromide, reminyl )对治疗伴有脑血管病或血管性痴呆的 ... 新�网河�频�

Focus on the World Alzheimer's and Parkinson's Disease Market  -  Sep 15, 2008
Cholinesterase Inhibitors (ChEIs) II-27 Donepezil (Aricept) II-27 Rivastigmine (Exelon) II-27 Galantamine Hydrobromide (Razadyne) II-28 Tacrine (Cognex) ... marketwire.com

Health authorities reviewing scientific data from trials evaluating …  -  Jan 24, 2005
...an investigational use of the company's Alzheimer's treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment. ... News-Medical.net

Article: Azathioprine tablets recalled.(Rheumatology)(Roxane …  -  Oct 1, 2006
...today the availability ... product is available as a generic from Roxane Laboratories. Roxane Laboratories' Galantamine Hydrobromide Oral Solution ... ... Pay-Per-View - Internal Medicine News - HighBeam Research

Press Release: Ranbaxy Receives Tentative Approval to Manufacture …  -  Aug 30, 2007
...approval from the U.S. Food and Drug Administration to manufacture and market Galantamine Hydrobromide Tablets, 4mg (base), 8mg (base), and 12mg (base). ... Pay-Per-View - PR Newswire - HighBeam Research

Dr Reddy`s gets USFDA nod for Nabumetone tablets  -  Oct 1, 2008
Recently, the company`s US subsidiary received tentative approval from the USFDA for Galantamine Hydrobromide tablets in the strengths of 4 mg, ... Myiris.com

Pivotal Phenserine Data Drop Axonyx's Stock By 62 Percent  -  Feb 8, 2005
Both Reminyl (galantamine hydrobromide, Shire Pharmaceuticals Group plc) and Exelon (rivastigmine tartrate, Novartis AG) are products that work by ... BioWorld Online - BioWorld Online

Article: Have I hurt myself by doing it too often?(Features) - Daily...  -  Dec 4, 2006
19 /PRNewswire/ -- Results from the first one-year, head-to-head study comparing REMINYL(R) (galantamine hydrobromide) and Aricept(R)* (donepezil ... Pay-Per-View - Daily Record - HighBeam Research

FDA Approves New Alzheimers Drug  -  May 23, 2005
Approved by the US Food and Drug Administration (FDA) in December 2004, RAZADYNE ER contains galantamine hydrobromide -- first approved by the FDA in ... WebProNews

Barr Pharmaceuticals (BRL) Receives FDA Approval for Generic …  -  Sep 16, 2008
...and market a generic version of Ortho McNeil Janssen's Razadyne® ER (galantamine hydrobromide extended release capsules), eq. to 8 mg, 16 mg and 24 mg. ... StreetInsider.com - StreetInsider.com (subscription)

Alzheimer's drug linked to higher mortality.(News)(Brief Article)  -  Mar 1, 2005
Canadian health authorities have issued a public advisory concerning the safety of galantamine hydrobromide as a treatment for mild cognitive impairment--an ... Free with registration - Clinical Psychiatry News - AccessMyLibrary.com

Cholinesterase Inhibitor Use in Dementia: Introduction  -  May 18, 2005
Reminyl (galantamine hydrobromide) package insert. Titusville, NJ: Janssen Pharmaceutica; 2003 Mar. Wilcock G, Howe I, Coles H et al. ... Medscape

Death link query over Reminyl.(Brief Article)  -  Feb 5, 2005
A study has linked Reminyl (galantamine hydrobromide) to slightly higher mortality rates when used in patients with mild cognitive impairment, ... Free with registration - Chemist & Druggist - AccessMyLibrary.com

Mild Cognitive Impairment Is Not a Clinical Entity and Should Not Be ...  -  Mar 31, 2005
...such as donepezil hydrochloride, rivastigmine tartrate, or galantamine hydrobromide, can delay the diagnosis of AD and/or improve cognitive impairments. ... Archives of Neurology

Press Release: Roxane Laboratories, Inc. Announces the Launch of …  -  Feb 7, 2007
...today the availability ... product is available as a generic from Roxane Laboratories. Roxane Laboratories' Galantamine Hydrobromide Oral Solution ... ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Roxane Laboratories, Inc. Resumes Shipments of …  -  Mar 7, 2006
...today the availability ... product is available as a generic from Roxane Laboratories. Roxane Laboratories' Galantamine Hydrobromide Oral Solution ... ... Pay-Per-View - PR Newswire - HighBeam Research

MYRIAD MOVING FLURIZAN INTO PHASE III ALZHEIMER'S TESTING.( …  -  Jan 13, 2005
...and Reminyl (galantamine hydrobromide, from Shire Pharmaceuticals Group plc). A more recently approved drug, Namenda (memantine HCL), is marketed in the US ... Pay-Per-View - BIOWORLD Today - Factiva, from Dow Jones

Telehealth licensure.(Policy & Practice)(Brief article) | Article...  -  Dec 1, 2006
...galantamine hydrobromide, Janssen) An acetylcholinesterase inhibitor for the treatment of mild to moderate dementia of the Alzheimer's type. ... Pay-Per-View - Family Practice News - HighBeam Research

When hairy met Sally.(Indications)(Brief article) | Article from...  -  Mar 15, 2007
...galantamine hydrobromide, Janssen) An acetylcholinesterase inhibitor for the treatment of mild to moderate dementia of the Alzheimer's type. ... Pay-Per-View - Family Practice News - HighBeam Research

Ortho-McNeil Modifies Precautions on Reminyl Following Trial Deaths  -  Apr 5, 2005
In the trials, a total of 13 subjects on Reminyl (galantamine hydrobromide) and one subject on placebo died, according to a March 31 Dear Healthcare ... Pay-Per-View - Drug Industry Daily - Factiva, from Dow Jones

J&J's 4th-qtr net earnings plunge 34%.(Johnson & Johnson )  -  Jan 31, 2005
Velcade (bortezomit), a treatment for patients with relapsed and refractory multiple myeloma; and Reminyl (galantamine hydrobromide), a mild-to-moderate ... $4.95 - Pharma Marketletter - ECNext

Alzheimer Disease; Health authorities review data from Reminyl...  -  Feb 14, 2005
...an investigational use of the company's Alzheimer treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment. ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones

J&J's new data on Reminyl in mild cognative impairment shows higher …  -  Jan 31, 2005
Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment, which showed a higher incidence of deaths in this indication. ... $4.95 - Pharma Marketletter - ECNext

EU researchers find potential new link between AD and amyloid plaques.  -  Jun 2, 2008
...received tentative approval from the US Food and Drug Administration to market the first approved AChe inhibitor for AD, galantamine hydrobromide. ... $9.94 - Pharma Marketletter - Alacra Store

Alzheimer Disease; Health authorities review data from Reminyl...  -  Feb 19, 2005
...an investigational use of the company's Alzheimer treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment. ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Top 10 cost half a trillion.(Policy & Practice)(Brief article) |...  -  Mar 1, 2008
...galantamine hydrobromide, Janssen) An acetylcholinesterase inhibitor for the treatment of mild to moderate dementia of the Alzheimer's type. ... Pay-Per-View - Family Practice News - HighBeam Research

News from the lubricated world.(Indications)(Brief Article) | Article...  -  Mar 1, 2005
...galantamine hydrobromide, Janssen) An acetylcholinesterase inhibitor for the treatment of mild to moderate dementia of the Alzheimer's type. ... Pay-Per-View - Family Practice News - HighBeam Research

Article: Reminyl safety watch.(investigations)(Brief Article)  -  Feb 7, 2005
The acetylcholinesterase inhibitor Reminyl (galantamine hydrobromide) is being reinvestigated by safety watchdogs, after two clinical trials suggested it ... Pay-Per-View - Chemistry and Industry - HighBeam Research

Medical watchdog recommends five new medicines  -  Jun 14, 2005
The Scottish Medicines Consortium has advised Galantamine hydrobromide should be accepted for the treatment of mild to moderately severe dementia in ... Pay-Per-View - Aberdeen Press & Journal - Factiva, from Dow Jones

New Botox revenue stream?(Indications)(Brief article) | Article from...  -  May 15, 2008
...galantamine hydrobromide, Janssen) An acetylcholinesterase inhibitor for the treatment of mild to moderate dementia of the Alzheimer's type. ... Pay-Per-View - Family Practice News - HighBeam Research

Alzheimer's drug linked to higher mortality.(Rx) | Article from...  -  Mar 1, 2005
Rx) ... find Internal Medicine News articles. Canadian health authorities have issued a public advisory concerning the safety of galantamine hydrobromide a. Pay-Per-View - Internal Medicine News - HighBeam Research

Trial Deaths Prompt Ortho-McNeil to Modify Precautions on Reminyl  -  Apr 12, 2005
In the trials, a total of 13 subjects on Reminyl (galantamine hydrobromide) and one subject on placebo died, according to a March 31 Dear Healthcare ... Pay-Per-View - FDAnews Drug Daily Bulletin - Factiva, from Dow Jones

Alzheimer Disease; Reminyl XL now available in UK and Ireland  -  Jul 12, 2005
2005 JUL 12 - (NewsRx.com) -- Shire Pharmaceuticals Group plc (SHP, SHPGY, SHQ) announces that Reminyl XL (galantamine hydrobromide) prolonged release ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Press Release: Roxane Laboratories, Inc. Initiates a Nationwide …  -  Jul 14, 2008
...today the availability ... product is available as a generic from Roxane Laboratories. Roxane Laboratories' Galantamine Hydrobromide Oral Solution ... ... Pay-Per-View - PR Newswire - HighBeam Research

Razadyne to get generic rival.(RX: RETAIL PHARMACY: Generic Drugs)( …  -  Sep 29, 2008
Administration to manufacture and market a genetic version of Ortho McNeil Janssen's Razadyne (galantamine hydrobromide), 4 mg, 8 mg and 12 mg tablets. ... Pay-Per-View - Chain Drug Review - HighBeam Research

Alzheimer Disease; Health authorities review data from Reminyl...  -  Feb 15, 2005
...an investigational use of the company's Alzheimer treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment. ... Pay-Per-View - Science Letter - Factiva, from Dow Jones

New generics win approval from the FDA.  -  Sep 29, 2008
...for example, was given approval to manufacture and market a genetic version of Ortho McNeil Janssen's Razadyne (galantamine hydrobromide) in 4-, ... $9.94 - Chain Drug Review - Alacra Store

Barr Laboratories.  -  Aug 22, 2005
...against the company relating to the patents protecting Razadyne (galantamine hydrobromide), formerly called Reminyl, in 4 mg, 8 mg and 12 mg tablets. ... $9.94 - Drug Store News - Alacra Store

Article: Vic: Quadriplegic can keep compo, court rules - AAP General ...  -  Dec 16, 2005
Shire plc (UK), which markets Reminyl (galantamine hydrobromide) and Reminyl XL for Alzheimer's in the UK, has stated that ... ... Pay-Per-View - AAP General News - HighBeam Research

Factiva Search  -  Mar 1, 2005
Canadian health authorities have issued a public advisory concerning the safety of galantamine hydrobromide as a treatment ... Copyright 2005 Gale Group. ... Pay-Per-View - Clinical Psychiatry News - Factiva, from Dow Jones

Article: Alzheimer's drug linked to higher mortality.(News)(Brief...  -  Mar 1, 2005
...find Clinical Psychiatry News articles. Canadian health authorities have issued a public advisory concerning the safety of galantamine hydrobromide a... Pay-Per-View - Clinical Psychiatry News - HighBeam Research

Press Release: SHIRE PLC - Shire welcomes the Court of Appeala[euro][...  -  May 1, 2008
NHS to drugs used for the treatment of Alzheimer's disease, which includes Shire's products ReminylA[R] and ReminylA[R] XL (galantamine hydrobromide). ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research

Aumento del rischio di morte con alcuni nuovi antipsicotici  -  Oct 21, 2005
Safety alerts for drugs, biologics, medical devices, and dietary supplements: Reminyl (galantamine hydrobromide). Rockville, Md.: Food and Drug ... Pillole.org

後発薬ã?®ãƒ?ーã€?アルツãƒ?イマー病治療薬ã?®ç‰¹è¨±è¨´è¨Ÿã?§å‹?訴  -  Aug 29, 2008
Janssen)�アルツ�イマー病治療薬「Razadyne錠 (galantamine hydrobromide)�4 ミリ�8ミリ�12ミリ�後発医薬������製造販売承��下り��発表��。 ... IP NEXT ニュース

マイランã€?アルツãƒ?イマー病治療薬ã?®ç‰¹è¨±è¨´è¨Ÿã?§å‹?訴  -  Sep 1, 2008
...�アルツ�イマー病治療薬「Razadyne錠 (galantamine hydrobromide)�4ミリ�8 ミリ�12ミリ�後発医薬�ガラタミン錠�関�る特許侵害訴訟��訴���発表��。 ... IP NEXT ニュース





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy